Holen Sie sich die Stockscreener-App
27.93
9.35%
-2.88
Olema Pharmaceuticals Inc Aktie (OLMA) Neueste Nachrichten
Why Olema Pharmaceuticals Inc. stock is favored by pension fundsJuly 2025 Closing Moves & Verified Momentum Stock Watchlist - Улправда
Olema Pharmaceuticals (NASDAQ: OLMA) Stock: Latest News, Analyst Forecasts, and What’s Driving the Volatility on December 19, 2025 - ts2.tech
Is Olema Pharmaceuticals Inc. stock positioned well for digital economyQuarterly Trade Report & Detailed Earnings Play Strategies - DonanımHaber
Will Olema Pharmaceuticals Inc. stock pay special dividendsJuly 2025 Big Picture & Daily Technical Stock Forecast Reports - Улправда
Why Olema Pharmaceuticals Inc. stock is popular among millennialsAnalyst Downgrade & Reliable Price Breakout Signals - Улправда
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 3.5%Time to Sell? - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Olema Pharmaceuticals Inc Stock Analysis and ForecastMomentum Trading Signals & Fast Profit Trading Tips - earlytimes.in
Olema Pharmaceuticals (NASDAQ:OLMA) Hits New 12-Month HighTime to Buy? - MarketBeat
Olema Oncology’s Stock Surge: Analyze Now? - timothysykes.com
Olema Oncology (OLMA) Sees Positive Surge in Stock Price - GuruFocus
Olema Pharmaceuticals Stock Surges Amid Analyst Optimism - TipRanks
Research Analysts Offer Predictions for OLMA FY2025 Earnings - MarketBeat
Lifesci Capital Has Positive Outlook of OLMA FY2025 Earnings - MarketBeat
Birchview Capital LP Invests $571,000 in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Price Target Raised to $48.00 - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Price Target Raised to $60.00 - MarketBeat
OLMA Stock: Citigroup Raises Price Target to $60, Maintains Buy - GuruFocus
Olema Pharmaceuticals (OLMA): HC Wainwright & Co. Raises Price T - GuruFocus
Olema Oncology (OLMA) Price Target Raised by Citi Amid Positive Trial Data - GuruFocus
Olema Pharmaceuticals (OLMA): Reassessing Valuation After Roche’s Phase 3 SERD Success Boosts Palazestrant Expectations - Sahm
Oppenheimer Raises Price Target for Olema Pharmaceuticals (OLMA) to $48 | OLMA Stock News - GuruFocus
OLMA: Goldman Sachs Raises Price Target to $38 on Maintained Buy Rating | OLMA Stock News - GuruFocus
The Goldman Sachs Group Issues Positive Forecast for Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 6% Following Analyst Upgrade - MarketBeat
Olema (OLMA) Hits 4-Year High as Jefferies Hikes PT - Finviz
HC Wainwright Raises Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $45.00 - MarketBeat
Olema Pharmaceuticals stock price target raised to $45 at H.C. Wainwright - Investing.com Canada
HighVista Strategies LLC Acquires 66,245 Shares of Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Roche's SERD Trial Boosts Olema Pharmaceuticals (OLMA) Stock - GuruFocus
Jefferies raises Olema Pharmaceuticals stock price target to $43 on SERD validation - Investing.com UK
Olema Pharmaceuticals (OLMA) Stock Hits New 52‑Week High on December 10, 2025: What Investors Need to Know - ts2.tech
Olema Pharmaceuticals (NASDAQ:OLMA) Hits New 1-Year HighHere's Why - MarketBeat
Olema Oncology (OLMA) Shares Surge Over 11% - GuruFocus
Olema Pharmaceuticals stock hits 52-week high at $29.57 By Investing.com - Investing.com Canada
Olema Pharmaceuticals stock hits 52-week high at $29.57 - Investing.com
Roche boosts Olema after additional late-stage trial data for breast cancer drug - Seeking Alpha
Diadema Partners LP Increases Stock Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals joins SABCS25 to advance breast cancer therapies - Traders Union
Olema Pharmaceuticals (NASDAQ:OLMA) Trading Down 7.7%Here's Why - MarketBeat
Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025 - ts2.tech
XTX Topco Ltd Makes New Investment in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals, Inc. $OLMA Shares Bought by Schroder Investment Management Group - MarketBeat
Affinity Asset Advisors LLC Lowers Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals (OLMA) price target increased by 53.92% to 37.23 - MSN
Why Olema Pharmaceuticals Inc. stock is rated strong buyChart Signals & Capital Protection Trade Alerts - Newser
Why retail investors favor Olema Pharmaceuticals Inc. stockMarket Sentiment Review & Long-Term Growth Plans - Newser
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Olema Pharmaceuticals seeks senior medical director to advance oncology care - Traders Union
Olema Pharmaceuticals (OLMA) Stock Analysis Report | Financials & Insights - Benzinga
H.C. Wainwright Backs Olema Pharmaceuticals (OLMA) as Phase 3 Trials Advance - MSN
Olema Pharmaceuticals (OLMA): Assessing Valuation Following $190 Million Equity Offering and Underwriter Changes - Sahm
Olema Pharmaceuticals (NASDAQ:OLMA) Reaches New 1-Year HighHere's What Happened - MarketBeat
Olema Pharmaceuticals stock hits 52-week high at 27.25 USD By Investing.com - Investing.com Canada
Olema Pharmaceuticals stock hits 52-week high at 27.25 USD - Investing.com
0.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):